Solomon Islands vs Türkiye: Prevalence rate of diabetes in adults
Solomon Islands
13.9
in 2014
Türkiye
13.6
in 2014
Solomon Islands rank
25th
Türkiye rank
27th
Prevalence rate of diabetes in adults over time
- Solomon Islands
- Türkiye
How they compare
Solomon Islands currently reports 13.9 against 13.6 in Türkiye, a difference of 0.3.
Across all 35 years both countries report, Solomon Islands has been ahead every year.
Solomon Islands ranks 25th and Türkiye ranks 27th of 190 countries.
Solomon Islands has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Solomon Islands | Türkiye | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 6.73 | 6 | 0.73 | Solomon Islands |
| 1990s | 8.97 | 8.02 | 0.95 | Solomon Islands |
| 2000s | 11.41 | 10.69 | 0.72 | Solomon Islands |
| 2010s | 13.3 | 13 | 0.3 | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of diabetes in adults, Solomon Islands or Türkiye?
- Solomon Islands, at 13.9 against 13.6 in Türkiye as of 2014.
- What is the difference in prevalence rate of diabetes in adults between Solomon Islands and Türkiye?
- 0.3, with Solomon Islands ahead.
- How many years of comparable data are there for Solomon Islands and Türkiye?
- 35 years are reported by both, from 1980 to 2014.
- How do Solomon Islands and Türkiye rank globally for prevalence rate of diabetes in adults?
- Solomon Islands ranks 25th and Türkiye ranks 27th of 190 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of diabetes in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of people with diabetes among those aged over 18, based on general population surveys and statistical modeling. Diabetes is a risk factor for chronic complications, including cardiovascular disease, and premature death.